FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Newsom’s ‘Golden State Start’ promises 400 free diapers per baby as California grapples with budget woes

U.S. military kills two alleged narco-terrorists in lethal strike on drug vessel in Eastern Pacific

Reckoning: Islamic Group with Terror Ties Set to Be Investigated by GOP

Trump Preparing to Fire FDA Commissioner Amid Nicotine Dispute and Pro-Life Outcry: Report

Video shows ICE officers arrest alleged MS-13 gang member described as ‘known suspected terrorist’ in Florida

Green Politician Wants to Limit Nursing Home Residents to 2.8 Oz of Meat per Week Due to Climate Change – That’s Less Than 1 Big Mac … Per Week

Obama Slammed for ‘Disgusting’ Decision to Speak at Event Organized by Man with Troubling Past

Utah Supreme Court justice resigns amid probe into alleged relationship with redistricting attorney

Fox News Campus Radicals Newsletter: Men admitted to all-women’s school, bizarre campus confrontation

James Comey criminal trial over ’86 47′ post set for July 15

Georgia mayor fires entire police department after officers complain about his wife in dispute

Virginia Democrat who helped lead state’s redistricting push also played part in killing it

Declassified Apollo mission UFO files challenge long-running Moon landing conspiracy theories

Human Remains Found Near Guthrie Home Create New Mystery, Fail to Solve Current One

Can’t Make It Up: Islamic Activist Behind ‘Muslims Only’ Waterpark Day Also Runs ‘Learing’ Center of Her Very Own

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”